Faculty profile

Linda Rabeneck

Back to faculty

ProfessorClinical Public Health DivisionUniversity of Toronto

Linda Rabeneck

Professor

Clinical Public Health Division

Dalla Lana School of Public Health

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
31 publications in the last five years, latest in 2026.
Senior (last) author on 6 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2012.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

159

Publications

1,159

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cancer Screening Community Readiness Determinants Of Health First Nations And Metis Health Policy Health System Knowledge Translation

Latest papers

Multicomponent audit and feedback for colonoscopy quality improvement among potentially lower-performing endoscopists
Journal of the Canadian Association of Gastroenterology · 2026
The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) - Cohort Description.
Cancer control : journal of the Moffitt Cancer Center · 2026
Global impact of COVID-19 on organized CRC screening programs: lessons learned.
Best practice & research. Clinical gastroenterology · 2026

All 159 publications

Latest funding

Survived, but overlooked: personalizing breast and colorectal cancer screening for survivors of adult cancers
CIHR · 2025 · Co-investigator
$100,000
Toward equity in cancer genetics: identifying racial disparities in cancer genetics services
CIHR · 2022 · Co-investigator
$734,400
Advancing cancer and chronic disease prevention in younger adults living with low income: a BETTER Life
CIHR · 2021 · Co-investigator
$99,947

All 12 grants and awards

From the 150 most recent of 159 publications.

Multicomponent audit and feedback for colonoscopy quality improvement among potentially lower-performing endoscopists

Llovet D, Patel J, Conn LG, Sargeant J, Baxter NN, Ivers N, Morgan D, Paszat L, Rabeneck L, Tinmouth J

Journal of the Canadian Association of Gastroenterology2026

DOI: 10.1093/jcag/gwag010

The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) - Cohort Description.

Brenner DR, Feng X, Maxwell C, Hutchinson JM, Carbonell C, Nambayan R, Rabeneck L, Tinmouth J, Forbes N, Heitman SJ, Sauro KM, Cuthbert C, O'Sullivan DE, Hilsden RJ

Cancer control : journal of the Moffitt Cancer Center2026

DOI: 10.1177/10732748251413334 PMID: 41510604

Global impact of COVID-19 on organized CRC screening programs: lessons learned.

de Jonge L, Lansdorp-Vogelaar I, Doria-Rose VP, Portillo I, Novak Mlakar D, Buron A, Quintin C, Espinàs JA, Plaine J, Škrjanec AL, Kofol Bric T, Binefa G, Font R, Bulliard JL, Chubak J, Ziebell R, McCurdy BR, Rabeneck L, Senore C, International Cancer Screening Network Colorectal Cancer working group

Best practice & research. Clinical gastroenterology2026

DOI: 10.1016/j.bpg.2025.102047 PMID: 41724540

Should we screen for colorectal cancer with biennial FIT beginning at age 45 in Canada?

Rabeneck L, Tinmouth J, Hutchinson JM, Ruan Y, Hilsden RJ, Warkentin MT, Telford JJ, Singh H, Dobrow MJ, Barkun AN, Llovet D, McGrath J, Sheppard AJ, Dubé C, du Plessis H, Wong CKW, Cleary SP, Coldman AJ, Heitman SJ, Senese LC, Brenner DR, Canadian Colorectal Cancer Screening Research Network

Journal of the Canadian Association of Gastroenterology2026First author

DOI: 10.1093/jcag/gwag008 PMID: 42058692

Blood Biomarkers of Glucose Metabolism and Liver Function Modestly Improve Prediction of High-Risk Adenomas.

Sutherland RL, Ruan Y, Warkentin MT, O'Sullivan DE, Forbes N, Cheung WY, Lix LM, Tinmouth J, Rabeneck L, Hilsden RJ, Brenner DR

Gastro hep advances2026

DOI: 10.1016/j.gastha.2026.100932 PMID: 42058585

When Should Colon Cancer Screening Begin? The Impact of Early-Onset Colorectal Cancer and the Reality of an Unscreened Older Population.

Lansdorp-Vogelaar I, Rabeneck L

Digestive diseases and sciences2025Senior author

DOI: 10.1007/s10620-024-08738-6 PMID: 39724471

Advancing prevention and screening in younger adults living with low income: development, piloting and acceptability/appropriateness evaluation of A BETTER Life.

Lofters AK, Devotta K, Makuwaza T, Lepine K, Aubrey-Bassler K, Donnelly PD, Fernandes C, Grunfeld E, Konkin J, Manca DP, Nykiforuk C, Paszat L, Pinto A, Rabeneck L, Sayani A, Selby P, Sopcak N, Wall B, O'Brien MA

Pilot and feasibility studies2025

DOI: 10.1186/s40814-025-01754-x PMID: 41408358

Optimizing the Harms and Benefits of Cervical Screening in a Partially Vaccinated Population in Ontario, Canada: A Modeling Study.

de Bondt DD, Jansen EEL, Stogios C, McCurdy BR, Kupets R, Murphy J, Costescu D, Rabeneck L, Truscott R, Hontelez JAC, de Kok IMCM

Medical decision making : an international journal of the Society for Medical Decision Making2025

DOI: 10.1177/0272989x251332597 PMID: 40260498

Risk-based lung cancer screening performance in a universal healthcare setting

Tammemägi MC, Darling GE, Schmidt H, Walker MJ, Langer D, Leung YW, Nguyen K, Miller B, Llovet D, Evans WK

Nature Medicine202438 citationsSenior author

DOI: 10.1038/s41591-024-02904-z

Interventions on gender equity in the workplace: a scoping review

Tricco AC, Parker A, Khan PA, Nincic V, Robson R, MacDonald H, Warren R, Cleary O, Zibrowski E, Baxter N

BMC Medicine202420 citations

DOI: 10.1186/s12916-024-03346-7

Profile data last refreshed on July 30, 2025 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Linda Rabeneck

Research

Latest papers

Latest funding

Multicomponent audit and feedback for colonoscopy quality improvement among potentially lower-performing endoscopists

The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) - Cohort Description.

Global impact of COVID-19 on organized CRC screening programs: lessons learned.

Should we screen for colorectal cancer with biennial FIT beginning at age 45 in Canada?

Blood Biomarkers of Glucose Metabolism and Liver Function Modestly Improve Prediction of High-Risk Adenomas.

When Should Colon Cancer Screening Begin? The Impact of Early-Onset Colorectal Cancer and the Reality of an Unscreened Older Population.

Advancing prevention and screening in younger adults living with low income: development, piloting and acceptability/appropriateness evaluation of A BETTER Life.

Optimizing the Harms and Benefits of Cervical Screening in a Partially Vaccinated Population in Ontario, Canada: A Modeling Study.

Risk-based lung cancer screening performance in a universal healthcare setting

Interventions on gender equity in the workplace: a scoping review

Frequent collaborators

Jill Tinmouth

Rinku Sutradhar

Lawrence Paszat

Diego Llovet

Aisha Lofters

Aisha Lofters

Shawn Forbes

Eva Grunfeld

Harminder Singh

Paul Ritvo

Peter Selby

Nancy Baxter

Harminder Singh

Paul Ritvo

William Evans

Nauzer Forbes

Anand Govindarajan

Andrew Pinto

Teresa To

Andrea Eisen

Andrea Eisen

Astrid Guttmann

Fahima Dossa

Candace Nykiforuk

Aaron Pollett

Rahim Moineddin

Monika Kastner

Wanrudee Isaranuwatchai

Julian Dobranowski

Cheryl Levitt

Natalie Coburn

Amit Garg

Andreas Laupacis

David Armstrong

Ivy Bourgeault

Hannah Geddie

Janet Raboud

David Geoffrey Morgan

Christopher McCabe

Christian John Finley